(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-2.90% $ 0.640
Live Chart Being Loaded With Signals
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc)...
Stats | |
---|---|
Volumen de hoy | 23 537.00 |
Volumen promedio | 220 504 |
Capitalización de mercado | 9.09M |
EPS | $0 ( 2024-03-07 ) |
Próxima fecha de ganancias | ( $-0.200 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.310 |
ATR14 | $0.0120 (1.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-14 | Darvish Nissim | Buy | 20 572 | Option to Purchase American Depositary Shares |
2021-04-19 | Darvish Nissim | Buy | 11 884 | Option to Purchase American Depositary Shares |
2016-10-28 | Darvish Nissim | Buy | 10 123 | Option to Purchase American Depositary Shares |
2023-03-16 | Darvish Nissim | Buy | 6 857 | Option to Purchase American Depositary Shares |
2022-03-07 | Darvish Nissim | Buy | 6 820 | Option to Purchase American Depositary Shares |
INSIDER POWER |
---|
-57.74 |
Last 88 transactions |
Buy: 2 375 207 | Sell: 4 584 307 |
Anchiano Therapeutics Ltd Correlación
10 Correlaciones Más Positivas | |
---|---|
SNGX | 0.895 |
LAWS | 0.894 |
NAKD | 0.892 |
DTSS | 0.891 |
CFMS | 0.886 |
IMV | 0.885 |
TNGX | 0.883 |
PIXY | 0.883 |
DBGI | 0.875 |
MRNA | 0.875 |
10 Correlaciones Más Negativas | |
---|---|
SJ | -0.906 |
MLTX | -0.893 |
ACVA | -0.893 |
PEGA | -0.888 |
KIN | -0.886 |
TA | -0.885 |
NCAC | -0.883 |
CONX | -0.879 |
NEO | -0.877 |
MYNA | -0.876 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Anchiano Therapeutics Ltd Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-66 827.00 (0.00 %) |
EPS: | $-2.06 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-66 827.00 (0.00 %) |
EPS: | $-2.06 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-57 773.00 (0.00 %) |
EPS: | $-2.43 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.200 |
Financial Reports:
No articles found.
Anchiano Therapeutics Ltd
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico